Generex Biotechnology Corp (GNBTQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 07-2005 | 07-2004 | 07-2003 | 07-2002 | 07-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,002 | -18,363 | -13,262 | -13,693 | -27,097 |
| Depreciation Amortization | 5,087 | 1,015 | 590 | 432 | 231 |
| Other Working Capital | 3,987 | -118 | -619 | -849 | 1,468 |
| Other Operating Activity | 3,528 | 1,584 | 1,322 | 378 | 2,737 |
| Operating Cash Flow | $-11,400 | $-15,882 | $-11,969 | $-13,732 | $-22,662 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 2,362 | 10,501 | 14,030 | -22,927 |
| PPE Investments | -64 | -646 | -506 | -780 | -1,623 |
| Purchase Sale Intangibles | -193 | -285 | -109 | -441 | -197 |
| Other Investing Activity | 216 | -630 | -214 | -1,168 | -1,204 |
| Investing Cash Flow | $152 | $1,085 | $9,781 | $12,082 | $-25,754 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 6,625 | N/A | N/A | N/A | N/A |
| Debt Issued | 816 | 161 | N/A | N/A | N/A |
| Debt Repayment | -98 | -73 | -60 | -9 | -5 |
| Common Stock Issued | N/A | 7,281 | 6,538 | 28 | 40,339 |
| Common Stock Repurchased | N/A | N/A | -88 | -396 | N/A |
| Other Financing Activity | -461 | 0 | 1 | 53 | 15,000 |
| Financing Cash Flow | $6,881 | $7,369 | $6,390 | $-325 | $55,333 |
| Exchange Rate Effect | 3 | 21 | 23 | -4 | -13 |
| Beginning Cash Position | 4,950 | 12,357 | 8,132 | 10,110 | 3,205 |
| End Cash Position | 587 | 4,950 | 12,357 | 8,132 | 10,110 |
| Net Cash Flow | $-4,364 | $-7,406 | $4,225 | $-1,978 | $6,905 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,400 | -15,882 | -11,969 | -13,732 | -22,662 |
| Capital Expenditure | -64 | -646 | -506 | -780 | -1,623 |
| Free Cash Flow | -11,464 | -16,528 | -12,475 | -14,512 | -24,285 |